GOLDSTEIN DOV A MD (CIK 1120478) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-04-24). Recent activity: Buy BIOA (3,542 shares), Buy BIOA (3,542 shares), Buy BIOA (3,541 shares), Buy BIOA (3,542 shares), Buy BIOA (27,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-24 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | Buy | 3,542 | $15,514 |
| 2026-03-03 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | Buy | 3,542 | $15,514 |
| 2026-02-03 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | Buy | 3,541 | $15,510 |
| 2026-01-21 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | Buy | 3,542 | $15,514 |
| 2026-01-15 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | Buy | 27,000 | $226,530 |
| 2026-01-15 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | Sell | 8,974 | $165,391 |
| 2026-01-15 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | Sell | 4,440 | $86,358 |
| 2026-01-15 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | Sell | 11,663 | $239,558 |
| 2026-01-15 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | Sell | 1,923 | $40,537 |
| 2025-08-19 | Coya Therapeutics, Inc. (COYA) | Director | Buy | 17,557 | $19,137 |
Source: SEC Form 4 filings · as of 2026-04-24